MNTL Holdings — Tema Neuroscience and Mental Health ETF
All 45 reported holdings of Tema Neuroscience and Mental Health ETF (MNTL) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Vertex Pharmaceuticals Inc | 10.46% | $1.02M |
| Regeneron Pharmaceuticals Inc | 6.48% | $629.52K |
| Alnylam Pharmaceuticals Inc | 6.22% | $603.64K |
| Argenx SE | 5.25% | $510.20K |
| Teva Pharmaceutical Industries | 4.99% | $484.29K |
| Neurocrine Biosciences Inc | 4.95% | $480.27K |
| Eli Lilly & Co | 4.16% | $403.51K |
| Crinetics Pharmaceuticals Inc | 4.11% | $398.64K |
| Biogen Inc | 3.34% | $324.60K |
| Stryker Corp | 3.14% | $305.35K |
| Catalyst Pharmaceuticals Inc | 2.92% | $283.35K |
| Ionis Pharmaceuticals Inc | 2.87% | $278.74K |
| Medtronic PLC | 2.54% | $246.95K |
| Axsome Therapeutics Inc | 2.52% | $244.71K |
| ACADIA Pharmaceuticals Inc | 2.35% | $228.56K |
| First American Treasury Obliga | 2.28% | $220.99K |
| Ucb SA | 2.23% | $216.60K |
| Denali Therapeutics Inc | 2.07% | $200.90K |
| Dexcom Inc | 1.97% | $191.42K |
| Alkermes PLC | 1.87% | $181.82K |
| Jazz Pharmaceuticals PLC | 1.86% | $180.69K |
| Xenon Pharmaceuticals Inc | 1.82% | $176.30K |
| Avidity Biosciences Inc | 1.72% | $167.04K |
| Penumbra Inc | 1.70% | $164.72K |
| Option Care Health Inc | 1.67% | $162.58K |
| PTC Therapeutics Inc | 1.56% | $151.58K |
| Scholar Rock Holding Corp | 1.44% | $140.29K |
| Siemens Healthineers AG | 1.36% | $131.96K |
| Sysmex Corp | 1.06% | $103.25K |
| Orion Oyj | 1.01% | $97.69K |
| Talkspace Inc | 0.91% | $88.79K |
| Immunovant Inc | 0.90% | $87.11K |
| Sarepta Therapeutics Inc | 0.75% | $73.06K |
| Day One Biopharmaceuticals Inc | 0.74% | $72.13K |
| Acadia Healthcare Co Inc | 0.61% | $58.77K |
| Eisai Co Ltd | 0.60% | $58.59K |
| Biohaven Ltd | 0.58% | $56.74K |
| Dyne Therapeutics Inc | 0.58% | $56.42K |
| Intellia Therapeutics Inc | 0.54% | $52.74K |
| Voyager Therapeutics Inc | 0.42% | $40.99K |
| Praxis Precision Medicines Inc | 0.42% | $40.67K |
| Prothena Corp PLC | 0.30% | $29.15K |
| Solid Biosciences Inc | 0.29% | $27.76K |
| Arvinas Inc | 0.15% | $14.93K |
| Rapport Therapeutics Inc | 0.13% | $12.40K |
MNTL overview: performance, fees, allocation and SEC filings